Education
About Us
Working with TipRanks
Follow Us
BioElectronics Corporation (BIEL)
OTHER OTC:BIEL
Total Valuation
BioElectronics has a market cap or net worth of $7.41M. The enterprise value is $20.95M.
Market Cap$7.41M
Enterprise Value$20.95M
Share Statistics
BioElectronics has 24,705,066,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding24,705,066,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
BioElectronics’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 20.93%.
Return on Equity (ROE)0.05
Return on Assets (ROA)-21.48
Return on Invested Capital (ROIC)20.93%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee55.11K
Profits Per Employee-103.41K
Employee Count9
Asset Turnover11.45
Inventory Turnover4.23
Valuation Ratios
The current PE Ratio of BioElectronics is ―. BioElectronics’s PEG ratio is 0.00.
PE Ratio―
PS Ratio9.96
PB Ratio-0.28
Price to Fair Value-0.28
Price to FCF-30.10
Price to Operating Cash Flow-45.15
PEG Ratio0.00
Income Statement
In the last 12 months, BioElectronics had revenue of 496.03K and earned -930.65K in profits. Earnings per share was 0.00.
Revenue496.03K
Gross Profit363.70K
Operating Income-392.69K
Pretax Income-930.65K
Net Income-930.65K
EBITDA-392.69K
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -472.15K and capital expenditures 0.00, giving a free cash flow of -472.15K billion.
Operating Cash Flow-472.15K
Free Cash Flow-472.15K
Free Cash Flow per Share>-0.01
Dividends & Yields
BioElectronics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.88
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
BioElectronics upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
BioElectronics as a current ratio of 0.01, with Debt / Equity ratio of -89.22%
Current Ratio0.01
Quick Ratio<0.01
Debt to Market Cap3.14
Net Debt to EBITDA-39.53
Interest Coverage Ratio-0.73
Taxes
In the past 12 months, BioElectronics has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
BioElectronics EV to EBITDA ratio is -52.12, with an EV/FCF ratio of -124.68.
EV to Sales41.26
EV to EBITDA-52.12
EV to Free Cash Flow-124.68
EV to Operating Cash Flow-124.67
Balance Sheet
BioElectronics has $6.87K in cash and marketable securities with $14.23M in debt, giving a net cash position of -$14.22M billion.
Cash & Marketable Securities$6.87K
Total Debt$14.23M
Net Cash-$14.22M
Net Cash Per Share>-$0.01
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is 73.32%, with operating margin of -79.17%, and net profit margin of -187.62%.
Gross Margin73.32%
Operating Margin-79.17%
Pretax Margin-187.62%
Net Profit Margin-187.62%
EBITDA Margin-79.17%
EBIT Margin-79.17%
Analyst Forecast
The average price target for BioElectronics is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―